H1N1 vaccine production insufficient
The alarming global count of 6.8 billion people who are mostly likely vulnerable to the new H1N1 virus, far surpasses the present production capacity of the influenza vaccines.
The WHO Director General, Margaret Chan, during her speech at the Intellectual Property and Public Policy Issues Conference stated that the seemingly limited production of the vaccines would mostly likely be absorbed by the affluent countries that would leave many other people worldwide devoid of the vaccine.
According to Chan, the preferred vaccine would be one that provides all rounded protection from the seasonal along with the whole range of associate endemic viruses. The director-general of WHO egged on the R&D sector along with the scholastics to actively pursue such a progress. She termed it as the finest and significantly logical insurance policy for augmenting production and supporting better unbiased access.
Chan pointed out the call for latest innovation stating that the global shortage of vaccines is the outcome of low production and not essentially due to intellectual property matters.
Chan asserted that the public health policy will continue to remain flawed until the access to effective medicines is prejudiced towards the affluent group. The global strategy agreement and action plan to be followed shows that the powers controlling the expansion and costing of medical supplies can be effectually directed towards better impartial medicine access.
Popularity: 1% [?]
